1. Home
  2. AGIO vs ROCK Comparison

AGIO vs ROCK Comparison

Compare AGIO & ROCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ROCK
  • Stock Information
  • Founded
  • AGIO 2007
  • ROCK 1972
  • Country
  • AGIO United States
  • ROCK United States
  • Employees
  • AGIO N/A
  • ROCK N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ROCK
  • Sector
  • AGIO Health Care
  • ROCK
  • Exchange
  • AGIO Nasdaq
  • ROCK Nasdaq
  • Market Cap
  • AGIO 2.4B
  • ROCK 2.0B
  • IPO Year
  • AGIO 2013
  • ROCK 1993
  • Fundamental
  • Price
  • AGIO $43.18
  • ROCK $64.04
  • Analyst Decision
  • AGIO Strong Buy
  • ROCK
  • Analyst Count
  • AGIO 4
  • ROCK 0
  • Target Price
  • AGIO $59.33
  • ROCK N/A
  • AVG Volume (30 Days)
  • AGIO 514.0K
  • ROCK 387.8K
  • Earning Date
  • AGIO 10-30-2025
  • ROCK 10-30-2025
  • Dividend Yield
  • AGIO N/A
  • ROCK N/A
  • EPS Growth
  • AGIO N/A
  • ROCK 10.96
  • EPS
  • AGIO 11.13
  • ROCK 4.18
  • Revenue
  • AGIO $40,875,000.00
  • ROCK $1,350,004,000.00
  • Revenue This Year
  • AGIO $23.74
  • ROCK N/A
  • Revenue Next Year
  • AGIO $159.90
  • ROCK $6.27
  • P/E Ratio
  • AGIO $3.77
  • ROCK $16.07
  • Revenue Growth
  • AGIO 30.57
  • ROCK 9.38
  • 52 Week Low
  • AGIO $23.42
  • ROCK $48.96
  • 52 Week High
  • AGIO $62.58
  • ROCK $75.08
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 50.11
  • ROCK 55.88
  • Support Level
  • AGIO $41.24
  • ROCK $67.41
  • Resistance Level
  • AGIO $44.25
  • ROCK $69.57
  • Average True Range (ATR)
  • AGIO 1.52
  • ROCK 2.70
  • MACD
  • AGIO -0.16
  • ROCK -0.15
  • Stochastic Oscillator
  • AGIO 31.28
  • ROCK 50.51

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

Share on Social Networks: